Department of Internal Medicine

 

References:

  • Liu Q, Bee MS, Schonbrunn A. (2009) Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.
  • Liu Q, Dewi DA, Liu WS, Bee MS, Schonbrunn A. (2008) Distinct phosphorylation sites in the sst2 somatostatin receptor control internalization, desensitization, and arrestin binding. Mol Pharmacol 73(2): 292-304
  • Cescato R, Schulz S, Waser B, Eltschinger V, Rivier JE, Wester HJ, Culler M, Ginj M, Liu Q, Schonbrunn A, Reubi JC. (2006) Internalization of sst2, sst3 and sst5 receptors: Effects of somatostatin agonists and antagonists. J Nucl Med 47 (3): 502-511
  • Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A. (2005) Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68 (1): 90-101.
  • Liu Q, Reubi JC, Wang Y, Knoll BJ, Schonbrunn A. (2003) In vivo phosphorylation of the somatostatin 2A receptor in human tumors. J Clin Endocrinol Metab 88 (12): 6073-6079.
  • Liu Q, Schonbrunn A. (2001) Agonist-induced phosphorylation of somatostatin receptor subtype 1 (sst1): relationship to desensitization and internalization. J Biol Chem 276(5): 3709-17.